Asset Manager

Updated:

Israel Innovation Authority

Israel Innovation Authority is a government agency based in Israel that supports innovation nationwide.

Israel Innovation Authority logo

Israel Innovation Authority

Israel Innovation Authority is a government agency based in Israel that supports innovation nationwide. It invests in the venture capital ecosystem, focusing on biotech and life sciences.

General information

Firm type

Generalist

Year founded

1965

AUM

Undisclosed

Location

Region

Middle East

Country

Israel

City

Jerusalem

Corporate office

Jerusalem Technology Park, Derech Agudat Sport Ha'poel 2, Jerusalem 9695102, Israel

Principals

Dror Bin

CEO

Alon Stopel

Chairman

Sector focus

Enterprise SoftwareDigital HealthAgriTech & FoodTechCybersecurityAI/MLClimateTechMobility & TransportationIndustrial TechEnergy Transition & Renewables

Frequently asked questions

Who runs investment decisions at the Israel Innovation Authority?

CEO Dror Bin and Chairman Alon Stopel lead the Authority, with investment committees structured by technology domain. The Authority operates under the Ministry of Innovation, Science and Technology, but grant and co-investment decisions are made by the Authority's professional staff through competitive review processes. Bin has an operator background as former CEO of RAD Communications.

How does the Israel Innovation Authority source its deal flow?

Deal flow arrives through open calls, a network of roughly 20 government-backed technological incubators, and direct relationships with Israeli venture firms that co-invest alongside the Authority's matching programs. The incubator network covers the country from the Galilee to the Negev. Multinationals like Stellantis also feed pipeline through bilateral R&D agreements.

Is the Israel Innovation Authority a sovereign wealth fund or a grant-making body?

It functions as a hybrid — deploying roughly $700 million annually through grants, conditional loans, and co-investment programs, but recouping capital through royalty streams on successful R&D outcomes rather than taking equity. This royalty-recovery model makes it self-financing over time, a structure the OECD has benchmarked as distinct from both pure subsidy programs and direct state investment vehicles.

What investment stages does the Authority typically target?

The Authority covers the full innovation lifecycle from academic research proof-of-concept through seed, early-stage venture, and growth-stage R&D. Its incubator program focuses on very early-stage startups, while the Yozma fund-of-funds program (relaunched in 2024) targets venture fund commitments. Direct R&D grants extend to established companies pursuing advanced development.

What is the Yozma Fund program, and why was it relaunched?

The original Yozma program, launched in 1993, was a government fund-of-funds that anchored Israel's first generation of venture capital firms by matching private commitments. Its 2024 relaunch aims to replicate that catalytic effect for the current cycle, providing state-backed LP capital to Israeli venture funds. The program is structured to crowd in private capital rather than displace it.

How is the Authority related to the Ministry of Innovation, Science and Technology?

The Authority operates as an independent statutory agency under the ministry's oversight but maintains budget and decision-making autonomy. This arms-length structure, established in 2016 when the Office of the Chief Scientist was converted into the Authority, was designed to insulate R&D allocation from short-term political pressure and allow multi-year program commitments.

Does the Authority maintain philanthropic or workforce-development programs?

Yes. The Human Capital for High-Tech Fund addresses Israel's technology workforce shortage through training and placement programs. The Societal Challenges Division funds R&D targeting public-sector needs in health, education, and social services. These are operated separately from the commercial R&D grant and co-investment programs.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Jerusalem Generalist profiles